NCT00090857View on ClinicalTrials.gov

Letrozole in Preventing Breast Cancer in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

August 31, 2008

Study Completion Date

March 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

OTHER

Placebo

Trial Locations (5)

77030

Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

02215

Beth Israel Deaconess Medical Center, Boston

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Jonsson Comprehensive Cancer Center

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00090857 - Letrozole in Preventing Breast Cancer in Postmenopausal Women | Biotech Hunter | Biotech Hunter